Key Takeaways
- Record order intake, Europe still a drag: Q2 order inflow hit an all-time high of INR 1,200 crores, yet reported EBITDA margin was just 10.3% because European entities lost INR 43 crores in H1.
- The backlog is getting healthier: The INR 2,446 crore record backlog was built when markets were softer; newer orders are expected to carry better profitability, setting up a margin recovery as they convert.[12-13]
- Restructuring benefits are back-end loaded: Germany is expected to at least break even in H2 FY27, with fuller benefits arriving in FY28; Swiss and top-management cost savings are also in motion, but the real payoff is next year.
- Non-traditional segments are reshaping the mix: Heavy Engineering, Process Systems, and Mixing Technologies are growing fast on defence, nuclear, thermal power, and peptides, reducing dependency on the subdued chemical sector.
- What to watch next quarter: Whether Germany actually breaks even, the pace of sequential margin improvement, and any quantified restructuring roadmap at the promised Investor Day.
European Restructuring: The Margin Overhang
- The core problem: Europe's chemical industry is going through a major reset with plant closures and low investment in new large-scale capacity, making the relatively high-cost base of GMM Pfaudler's European operations difficult to sustain at current business volumes.
- H1 FY27 impact: Loss-making European entities reported an EBITDA loss of approximately INR 43 crores, dragging reported group EBITDA margin to 10.2%; excluding these entities, the core 80% of the business operated at 14%–15% EBITDA margin.
- Germany: Workforce reduction of 40+ employees completed last year with costs fully accounted for; no real benefit seen in Q1 or Q2 FY27, some benefit expected in Q3, more in Q4, and "a lot more in Q1 of next year." The entity is expected to at least break even in H2 FY27 and be profitable next year.
- Switzerland: Restructuring of 8–10 people out of approximately 30 is under implementation; the entity is described as "super expensive," so even small headcount reductions yield significant cost benefit. Benefits expected next financial year; no material additional restructuring costs expected.
- UK: Restructuring completed two years ago; the UK entity is now profit-making.
- Structural shift to low-cost manufacturing: Manufacturing activities are progressively shifting to Poland, with a facility expansion expected to come online end of FY27 or start of FY28; over time, Europe is expected to have a rationalized operating model with India and Poland as low-cost manufacturing hubs while retaining strategic technology and business capabilities in Western Europe.
- Top management reorganization: The position of CEO International has been eliminated and a new Group CFO (Ankit Nayyar) is in place; these cost savings have already played through H1, with some residual benefit in H2 and none next year for the CEO International role.
Gelhaus: "The transformational structural exercise aimed at addressing the underlying issues in our operations rather than providing short-term relief."
Order Intake & Backlog: Record Highs, Improving Quality
- Highest-ever quarterly order inflow: Q2 FY27 order intake crossed INR 1,000 crores for consecutive quarters and reached INR 1,200 crores, driven by India order intake of INR 483 crores (also a record, more than double sequentially) because of large orders in the Heavy Engineering business and broad-based contributions from all four divisions.
- Backlog quality is improving: The backlog currently being executed was booked when markets were softer and demand slower; the newer backlog in hand today is expected to be more profitable, setting up a margin tailwind as it converts. [12-13]
- Record backlog visibility: The INR 2,446 crore backlog provides good visibility for H2 FY27 and carries momentum into FY28.
- Factory utilization: The Indian factory is full and Heavy Engineering is booked out till Q2 of next year; higher volumes are expected to improve benefits from the Shikhar cost-reduction program through operating leverage.
Tarak Patel: "The backlog that we are eating into right now obviously came at a time when the markets were obviously a lot softer, demand was slower, and hopefully going forward, the backlog that we have in our hands today is obviously more profitable." [12-13]
Segment Performance
| Division | Revenue Trend | Order Intake Trend | Commentary |
|---|---|---|---|
| Heavy Engineering (HET) | ▲ Up 38% YoY, 24% QoQ | ▲ Up 254% YoY, 248% QoQ | Large Africa order spanning oil & gas, petrochemicals, fertilizer; nuclear work with NPCIL and Megha Engineering; breakthrough into thermal power with LP and HP heater orders. |
| Process Systems (PST) | ▲ Up 57% YoY, 8% QoQ | — | Strong growth driven by mixing business in critical minerals, rare earths, and data centre/AI applications. |
| PPT (Mixing Technologies) | ▲ Up 34% YoY, 30% QoQ | ▲ Up 85% YoY, flat QoQ | Growth from rare earths and minerals for data centres and AI. |
| Corrosion Resistant Technologies (CRT) | ▬ Flat YoY, up 7% QoQ | ▲ Up 15% YoY, 11% QoQ | Chemicals remain subdued with only spurts in specialty and agrochemicals; pharma/CDMO is the main driver globally. China order intake in glass-lined improved unexpectedly, and the China factory will now be full. India glass-lined demand driven by Hyderabad pharma companies continuing to add capacity. |
- Non-traditional mix shift: The share of non-traditional sectors (PPT, HET, PST) will keep growing, and dependency on chemicals and pharma will keep reducing. Five years ago, 80%–90% of business came from chemical pharma and glass-lined; today the company describes itself as a "global diversified engineering company."
End-Market Opportunities
- Peptides: Described as a "once-in-a-generation drug"; current visible demand is "only the tip of the iceberg." European companies are expected to take 4–5 years to add peptide capacity, giving India and China a speed advantage. The company is well-positioned with installations already running in India with global majors. [14-15]
- Defence in Europe: Europe has not built a TNT plant since the 1980s; the company's products and technology are going into NATO-sponsored projects for TNT and nitrocellulose, with inquiries expected to continue over the next few quarters. The US could be another future opportunity as stocks deplete, though management noted this as a possibility they may focus on.
- Nuclear: Five new nuclear reactors are planned in India; L&T and other Indian companies have been approved, and private participation is expected eventually. The company is bullish and wants to grow market share.
- Thermal power: Breakthrough orders received for LP heaters and HP heaters; nuclear and thermal power will remain an important part of the growth story for HET.
- Semiconductors (US): Edlon has high-purity systems for fab and semiconductor chemicals; a new head of Edlon with 26 years of industry experience has been hired, and a new facility has opened in the US. Management is assessing whether Edlon can double or triple in 2–3 years, go global, and bring technologies to India for semiconductor growth.
Tarak Patel: "I think what we are seeing is only the tip of the iceberg. ... Every person over the age of 45, man or woman coming in, they are going to be on GLP-1s or peptides."
Margins & Profitability
- Reported vs. core margins: Q2 reported EBITDA margin was 10.3%, weighed down by European losses; excluding loss-making entities, the core 80% of the business delivered 14%–15% EBITDA margin.
- Gross margin trajectory: Gross margins reduced in Q2 because of loss-making entities, but EBITDA margins still improved sequentially on operating leverage from top-line growth. Management expects gross margins to improve over H2 and return to levels delivered over the last few years, and is confident they will come back to levels seen in the past.
- Sequential improvement path: Q1 to Q2 showed sequential margin improvement; the objective is to keep growing margins quarter-on-quarter, with H2 expected to be "definitely stronger" on better operating leverage, better costs, and economies of scale.
- Core business floor: A 15% core business EBITDA margin is "definitely achievable" even in a down cycle, per management.
- Finance costs: INR 116 crores of net debt repaid in H1; interest cost expected to be lower than last year, with some other initiatives being pushed to close faster than planned.
- Tax rate: ETR was 49% in FY26; some improvement expected in FY27, with the endeavour to reach 30% or lower. Tax restructuring initiatives are already showing results, with Q2 tax rate lower than Q1.
Tarak Patel: "It is not far off to say as a company, a 15% core business EBITDA margin is not something that is crazy. This is definitely achievable."
Transformation Program & FY28 Outlook
- Five workstreams for FY28: (1) Four global technology divisions fully established with clear ownership; (2) reduced European drag as restructuring benefits show in group margins; (3) group initiatives gaining traction with cost efficiencies and greater use of low-cost manufacturing sites; (4) stronger earnings conversion from lower financing costs and simpler legal/tax structure; (5) strong order book carrying momentum into FY28.
- New organizational structure: The four global technology divisions (announced after Q1) are now in place and already helping improve from gross margin to EBITDA.
- Refinancing and debt reduction: A group-wide refinancing program is progressing; lower finance costs and reduced FX volatility are expected to support improved earnings and greater predictability.
- Tax and legal entity simplification: On track with timelines; will help streamline intercompany transactions, improve tax efficiencies, and support better capital allocation.
- Investor Day: Planned "shortly in the coming months"; will provide a clear plan with a breakdown of savings from restructuring, operating leverage, and other items. Management declined to confirm specific FY28 margin expectations, asking investors to "wait a couple of months."
Gelhaus: "We expect FY 2028 to be an important year for the benefits of our transformation program."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Revenue growth | Double-digit YoY growth | FY27 |
| Reported EBITDA margin | About 10%–11%, including loss-making entities | FY27 |
| Adjusted EBITDA margin (core 80%) | 14%–15% | FY27 |
| Germany breakeven | At least we will not lose money | H2 FY27 |
| Germany profitability | In a position to make money | FY28 |
| Swiss restructuring benefits | Benefits to accrue | FY28 |
| Tax rate | 30% or lower | FY28 |
| Poland facility expansion | Extra capacity online | End FY27 / start FY28 |
| Investor Day | Clear plan with savings breakdown | "Coming months" |
| Core business EBITDA margin floor | 15% achievable even in a down cycle | Ongoing |
Key Metrics
| Metric | Q2 FY27 |
|---|---|
| Order intake | ₹1,198 cr, up 36% YoY and 19% QoQ; highest-ever quarterly order inflow |
| India order intake | ₹483 cr, highest ever and more than double sequentially |
| Order backlog | ₹2,446 cr, up 14% YoY; record high |
| Consolidated revenue | ₹1,065 cr, up 18% YoY and 15% QoQ |
| Reported EBITDA | ₹110 cr, improving 18% QoQ; margin of 10.3% |
| EBITDA excl. loss-making entities | ₹139 cr, margin of 15.9% |
| H1 FY27 loss-making European entities EBITDA loss | ~₹43 cr |
| Profit after tax | ₹35 cr, compared with ₹38 cr in Q2 FY26, up 59% QoQ |
| H1 FY27 net debt repaid | ~₹116 cr |
| Non-traditional industries share of Q2 orders | 44% |
| Corrosion Resistant Technologies revenue | ₹500 cr, flat YoY, up 7% QoQ |
| PPT revenue | ₹331 cr, up 34% YoY and 30% QoQ |
| HET revenue | ₹92 cr, up 38% YoY and 24% QoQ |
| PST revenue | ₹142 cr, up 57% YoY and 8% QoQ |
| FY27 reported EBITDA margin guidance | 10%–11%, including loss-making entities |
| FY27 adjusted EBITDA margin guidance (excl. loss-making entities) | 14%–15% |